MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-UP-29-0041510
Ravesan Pharmaceuticals Private Limited
Ravesan Pharmaceuticals Private Limited - chemicals in Ghaziabad, Uttar Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2023
₹51.99 Lakh
▼ 27% YoY
Net profit · FY 2023
₹34,413
Net margin 0.7%
EBITDA · FY 2023
₹2.76 Lakh
EBITDA margin 5.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹20 Lakh
Secured borrowings
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
About Ravesan Pharmaceuticals Private Limited
Data last updated:
Ravesan Pharmaceuticals Private Limited is a private limited company based in Ghaziabad, Uttar Pradesh, India. It operates in the medicinal chemical and botanical products segment of the chemicals sector. It was incorporated on 20 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24110UP2016PTC088505. Its GSTIN is 09AAICR0311E1ZT (Uttar Pradesh).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Santosh Bhat and Ravender Kumar Bhat.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at Flamingo 9th Floor Savior Park, Ghaziabad, Uttar Pradesh.
As per the financials filed for FY 2023, the company reported a revenue of ₹51.99 Lakh, a decline of 27% compared to the previous year. For the same year it recorded a net profit of ₹34,413 (net margin 0.7%) and EBITDA of ₹2.76 Lakh (EBITDA margin 5.3%). Revenue has declined at a compounded annual rate (CAGR) of 26% over three years and 7% over five years.
As per MCA filings, the company has open charges of ₹20 Lakh on record.
Ravesan Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-UP-29-0041510). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24110UP2016PTC088505
Registration Number 088505
Incorporation Date 20 December 2016
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2023
Date of Balance Sheet 31 March 2023
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-UP-29-0041510
Recognitions & Rankings of Ravesan Pharmaceuticals
Contact details
Ravesan Pharmaceuticals Private Limited's registered office is in Ghaziabad, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressA1/903 Tower No.B1/Flamingo 9th Floor Savior Park 108 Katori Mill Mohan Nagar Loni Road, Karhera, Ghaziabad, Uttar Pradesh, India – 201007
- IndustryChemicals, Medicinal Chemical & Botanical Products, Pharmaceuticals, Chemical Products
To see the full contact details of Ravesan Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Ravesan Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Ravesan Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ravesan Pharmaceuticals Private Limited, buy the company report.
Financials of Ravesan Pharmaceuticals Private Limited
FY 2023 filings availableRavesan Pharmaceuticals Private Limited reported revenue of ₹51.99 Lakh (down 27% YoY) for FY 2023.
Revenue · FY 2023
₹51.99 Lakh ▼ 27%
Net profit · FY 2023
₹34,413 margin 0.7%
EBITDA · FY 2023
₹2.76 Lakh margin 5.3%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 27%
3 years · compounded
▼ 26%
5 years · compounded
▼ 7%
EBITDA CAGR growth
1 year
▲ 141%
3 years · compounded
▼ 4%
5 years · compounded
▲ 19%
Revenue has declined at a compounded annual rate (CAGR) of 7% over five years, including a 27% fall in the latest year. EBITDA rose 141% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.76 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹34,413 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.3% | ||||
| Net Profit Margin | 0.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ravesan Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ravesan Pharmaceuticals Private Limited
Ravesan Pharmaceuticals has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Santosh Bhat | Director | 20 Dec 2016 | 9 Years 10 Months | Current |
| Ravender Kumar Bhat | Director | 20 Dec 2016 | 9 Years 10 Months | Current |
Auditor
Ravesan Pharmaceuticals Private Limited is audited by Shiv Raj Sohan & Co. for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Shiv Raj Sohan & Co. | FY 2017 | 021365N |
Shareholding
The shareholding of Ravesan Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Ravesan Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹20 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Oct 2018 | 100241072 | Others | ₹20 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ravesan Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ravesan Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ravesan Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAICR0311E1ZT | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Ravesan Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ravesan Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Ravender Kumar Bhat was appointed as Director on 20 Dec 2016.
AGM
Ravesan Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Ravesan Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Kanpur.
Charges
A charge with Others amounted to Rs. 20.00 Lakh with Charge ID 100241072 was registered on 12 Oct 2018.
Appointed
Ravender Kumar Bhat was appointed as Director.
Appointed
Santosh Bhat was appointed as Director.
Incorporation
20 Dec 2016
Ravesan Pharmaceuticals Private Limited was registered on 20 Dec 2016 with Roc Kanpur & aged 9 years 10 months as per MCA records.
Frequently asked questions
Ravesan Pharmaceuticals is an active private limited company based in Ghaziabad, Uttar Pradesh, India. The company works in medicinal chemical and botanical products, within the chemicals industry. It was incorporated on 20 December 2016 (10+ years old) and is registered under CIN U24110UP2016PTC088505.
Ravesan Pharmaceuticals has 2 current directors:
- Santosh Bhat - Director
- Ravender Kumar Bhat - Director
The latest financial statements of Ravesan Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Ravesan Pharmaceuticals is 09AAICR0311E1ZT, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Ravesan Pharmaceuticals is U24110UP2016PTC088505. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ravesan Pharmaceuticals was incorporated on 20 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Kanpur.
Ravender Kumar Bhat was appointed as Director on 20 Dec 2016. Santosh Bhat was appointed as Director on 20 Dec 2016.
Yes, Ravesan Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-UP-29-0041510).
The registered office of Ravesan Pharmaceuticals is at A1903 Tower No.B1Flamingo 9th Floor Savior Park 108 Katori Mill Mohan Nagar Loni Road, Karhera, Ghaziabad, Uttar Pradesh, India – 201007.
Ravesan Pharmaceuticals operates in the chemicals industry, in the medicinal chemical and botanical products segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages